Pharma Marketing News | Subscribe | Discussion Forums | Roundtable | Podcasts | Blog
Daily News Briefs | Surveys | Resources/Links | Glossary | Case Studies | Reports
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy

---

When patients fail to take their medicine as prescribed, the financial impact on the pharmaceutical industry is substantial. Even more distressing is the damage that is done to a patient's health and well being. Both the financial and social implications of non-compliance were the subjects of the recent 7th Annual Forum on Patient Compliance, Adherence and Persistency held in Philadelphia. This article presents highlights from this forum and discusses several issues, including: What does Adherence Mean? You Can't Control What You Don't Measure Return on Investment Who influences Adherence? Do We Really Know What It Costs? Pharmacist Perspective Business Case: Vaccine/Text Messaging Walgreens' Approach New Technology Invasive Compliance: A Bitter Pill to Swallow Keeping it Legal Winners of the Third Annual Strategic Patient Adherence (SPA) Awards

Order and pay for this reprint now using your credit card...

ONLY $6.95
Download PDF file immediately after paying:

PMN75-01
Issue: Vol. 7, No. 5: May 2008
Word Count: 3841

Find other articles in related Topic Areas:

• Direct-to-Consumer (DTC) Advertising & Marketing
• Compliance Marketing & Education
• Patient Education
• Regulatory Compliance